National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$85.50
add to cart

Rights & Permissions

topleft topright

The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary (2010)
Board on Global Health (BGH)

Citation Manager

. "A5 In Vitro and In Vivo Characterization of New Swine-Origin H1N1 Influenza Viruses." The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary. Washington, DC: The National Academies Press, 2010.

Please select a format:

BibTeX EndNote RefMan


Page
157
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


The Domestic and International Impacts of the 2009-H1N1 Influenza a Pandemic: Global Challenges, Global Solutions - Workshop Summary

In MDCK cells and primary human airway epithelial cells, CA04 grew to titres comparable to those typically obtained for contemporary human H1N1 influenza viruses (Supplementary Figure A5-4). Confocal, transmission electron and scanning electron microscopy revealed virions of remarkably filamentous shape (Supplementary Figure A5-5), in marked contrast to the spherical shape observed with negatively stained virions (http://www.cdc.gov/h1n1flu/images.htm). The biological significance of the morphology of CA04 remains unknown.

To evaluate the pathogenicity of S-OIV in mammalian models, we conducted studies in mice, ferrets, non-human primates and pigs. BALB/c mice intranasally infected with a high dose (>104 plaque forming units (p.f.u.)) of CA04 (Supplementary Figure A5-6) experienced weight loss and those infected with the highest dose of this virus were humanely killed, in contrast to animals infected with a recent human H1N1 virus (A/Kawasaki/UTK-4/09, KUTK-4). The 50% mouse lethal dose (MLD50) was 105.8 p.f.u. for CA04 and .106.6 p.f.u. for KUTK-4. For the additional S-OIV isolates tested, the MLD50 values were >106.4 p.f.u. for Osaka164, >106.6 p.f.u. for WSLH049, 104.5 p.f.u. for WSLH34939 and >105.8 p.f.u. for Net603.

On day 3 after infection of mice, similar titres were detected in nasal turbinates of mice infected with 105 p.f.u. of S-OIVs or KUTK-4 (Supplementary Table A5-2); however, S-OIVs replicated more efficiently in the lungs of infected animals, which may account for the prominent bronchitis and alveolitis with viral antigen on day 3 after infection with CA04 (Supplementary Figure A5-7a, b). On day 6 after infection, virus titres followed a similar trend and the lungs of CA04-infected mice showed bronchitis and alveolitis with viral antigen, although signs of regeneration were apparent (Supplementary Figure A5-7c). We detected viral-antigen-positive bronchial epithelial cells, but not alveolar cells, on day 3 after infection of mice infected with KUTK-4 (Supplementary Figure A5-7e). By day 6, infection in KUTK-4-inoculated mice had progressed to bronchitis and peribronchitis; however, viral antigen was rarely detected in these lesions (Supplementary Figure A5-7f).

There were marked differences in the induction of pro-inflammatory cytokines in the lungs of mice infected with CA04 compared with KUTK-4 (Supplementary Figure A5-8ac). Infection with KUTK-4 resultedin limited induction of pro-inflammatory cytokines/chemokines in the lungs, inmarked contrast to infection withCA04. Increased production of interleukin-10 (IL-10; Supplementary Figure A5-7a) in lungs of CA04-infected mice at day 6 after infection probably reflects a host response to dampen over-exuberant pulmonary inflammation and promote tissue repair. Infection with CA04 led to strong induction of both interferon-γ (IFN-γ) and IL-4 in the lungs. The selective induction of the TH2 cytokine IL-5 in CA04-infected, but not in KUTK-4-infected, mice on day 6 after infection is noteworthy (Supplementary Figure A5-7b), but further studies are needed to understand the relevance of this finding to viral control. IL-17 has been reported to have a role in protection against lethal influenza and also in eliciting

Page
157
Front Matter (R1-R22)
Workshop Overview (1-94)
Appendix A1 Technical Report for State and Local Public Health Officials and School Administrators on CDC Guidance for School (K-12) Responses to Influenza during the 2009-2010 School Year (95-110)
A2 Predicting Emerging Diseases in the Twenty-first Century: The Case of Zoonotic Influenza (111-119)
A3 The Spring 2009 Influenza A H1N1 Outbreak: A Local Public Health Perspective (120-136)
A4 I nternational Law and Equitable Access to Vaccines and Antivirals in the Context of 2009-H1N1 Influenza (137-154)
A5 In Vitro and In Vivo Characterization of New Swine-Origin H1N1 Influenza Viruses (155-190)
A6 Estimation of the Reproductive Number and the Serial Interval in Early Phase of the 2009 Influenza A⁄H1N1 Pandemic in the USA (191-207)
A7 The Severity of Pandemic H1N1 Influenza in the United States, from April to July 2009: A Bayesian Analysis (208-247)
A8 Hard Choices in Difficult Situations: Ethical Issues in Public Health Emergencies (248-268)
A9 Rumors of Pandemic: Monitoring Emerging Disease Outbreaks on the Internet (269-282)
A10 Preliminary Observation of the Epidemiology of Seasonal and Pandemic Influenza A (H1N1) in South Africa, 2009 (283-296)
A11 Reflections on the 1976 Swine Flu Vaccination Program (297-305)
A12 Southern Hemisphere, Northern Hemisphere: A Global Influenza World (306-326)
A13 Influenza (H1N1) Pandemic 2009 (327-341)
A14 Origins and Evolutionary Genomics of the 2009 Swine-Origin H1N1 Influenza A Epidemic (342-380)
Appendix B Agenda (381-385)
Appendix C Acronyms (386-388)
Appendix D Glossary (389-396)
Appendix E Forum Member Biographies (397-418)